18 July 2024 | Thursday | News
Image Source : Public Domain
Avallano is launching ProtocolCopilot™, an innovative AI-driven clinical research protocol assistant designed to transform the way biopharmaceutical companies and clinical research sites manage and interact with complex clinical trial protocols.
ProtocolCopilot leverages advanced artificial intelligence to streamline the process of understanding and adhering to clinical research protocols. By providing a chatbot interface, it ensures that users can effortlessly access crucial protocol information without the need to navigate through cumbersome documents. Key features of ProtocolCopilotTM include:
With ProtocolCopilot, clinical research professionals can focus more on critical tasks rather than getting bogged down by extensive protocol documents. This tool is especially beneficial for site staff who are often overwhelmed by the cognitive demands of managing numerous studies simultaneously.
"We are excited to bring ProtocolCopilotTM to the market, offering a cutting-edge solution that not only enhances efficiency but also supports compliance and accuracy in clinical research," said Paul Della Maggiora, CEO of Avallano. "By leveraging the power of AI, we are addressing a significant pain point in the industry and empowering research professionals with a tool that understands their needs."
Avallano is seeking early partners for the testing and deployment of ProtocolCopilot™.
Most Read
Bio Jobs
News
Editor Picks